CANOSA, Antonio
 Distribuzione geografica
Continente #
NA - Nord America 3434
EU - Europa 2707
AS - Asia 1129
SA - Sud America 35
OC - Oceania 24
AF - Africa 10
Continente sconosciuto - Info sul continente non disponibili 7
Totale 7346
Nazione #
US - Stati Uniti d'America 3355
IT - Italia 913
CN - Cina 593
IE - Irlanda 397
SE - Svezia 294
AT - Austria 245
KR - Corea 242
FR - Francia 199
DE - Germania 139
FI - Finlandia 96
GB - Regno Unito 94
VN - Vietnam 92
UA - Ucraina 77
CA - Canada 73
IN - India 60
JP - Giappone 56
PL - Polonia 55
BE - Belgio 44
ES - Italia 38
NL - Olanda 27
UZ - Uzbekistan 27
AU - Australia 22
BR - Brasile 17
TR - Turchia 16
RU - Federazione Russa 13
GR - Grecia 10
HK - Hong Kong 10
CO - Colombia 9
CZ - Repubblica Ceca 9
PT - Portogallo 9
DK - Danimarca 8
BG - Bulgaria 7
EU - Europa 7
HR - Croazia 6
TW - Taiwan 6
CH - Svizzera 5
IL - Israele 5
MX - Messico 5
RO - Romania 5
SG - Singapore 5
BA - Bosnia-Erzegovina 4
BY - Bielorussia 4
SN - Senegal 4
AR - Argentina 3
CL - Cile 3
IR - Iran 3
PH - Filippine 3
ID - Indonesia 2
MK - Macedonia 2
MT - Malta 2
MU - Mauritius 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
TN - Tunisia 2
UY - Uruguay 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
CR - Costa Rica 1
CY - Cipro 1
EC - Ecuador 1
HU - Ungheria 1
IM - Isola di Man 1
KZ - Kazakistan 1
LB - Libano 1
MO - Macao, regione amministrativa speciale della Cina 1
MY - Malesia 1
RS - Serbia 1
SA - Arabia Saudita 1
TH - Thailandia 1
Totale 7346
Città #
Chandler 791
Dublin 387
Beijing 341
Torino 293
Vienna 241
Fairfield 232
Houston 159
Wilmington 145
Ann Arbor 136
Princeton 118
Medford 116
Villeurbanne 114
Jacksonville 110
Nyköping 110
Woodbridge 106
Ashburn 105
Seattle 97
Cambridge 86
Redwood City 83
Fremont 58
Dearborn 55
Dong Ket 54
Milan 52
Warsaw 51
Boston 46
Pisa 45
Hangzhou 35
Turin 35
Chengdu 29
Brussels 28
Toronto 28
Boardman 21
Paris 19
Seoul 18
Cervignano Del Friuli 17
Falls Church 16
Hebei 16
Ottawa 16
Shanghai 16
Chicago 15
Norwalk 15
Rome 14
San Diego 14
Tokyo 14
Nanjing 12
Hefei 11
Guangzhou 10
Mountain View 10
Bologna 9
Duncan 9
Genova 9
Guiyang 9
Kunming 9
New York 9
Cagliari 8
Padova 8
Silver Spring 8
Bengaluru 7
Bethesda 7
London 7
San Mauro Torinese 7
Xian 7
Zhengzhou 7
Amsterdam 6
Detroit 6
Fuzhou 6
Limoges 6
Munich 6
Oxford 6
Phoenix 6
Portadown 6
Prague 6
Salerno 6
São Paulo 6
Waanrode 6
Wuhan 6
Buffalo 5
Florence 5
Istanbul 5
Nanchang 5
Napoli 5
Nürnberg 5
Palermo 5
Sofia 5
Taipei 5
Tours 5
Venteuil 5
Verona 5
Atlanta 4
Barnsley 4
Berlin 4
Castelnuovo Rangone 4
Central District 4
Dresden 4
Hamburg 4
Hanoi 4
Jinan 4
Lagarto 4
Las Vegas 4
Philadelphia 4
Totale 4846
Nome #
Amyotrophic lateral sclerosis outcome measures and the role of albumin and creatinine: a population-based study 480
The metabolic signature of C9ORF72-related ALS: FDG PET comparison with nonmutated patients. 367
Acoustic reflex patterns in amyotrophic lateral sclerosis 258
ATXN2 is a modifier of phenotype in ALS patients of Sardinian ancestry 199
Pathogenic VCP mutations induce mitochondrial uncoupling and reduced ATP levels. 174
Validation of the revised classification of cognitive and behavioural impairment in ALS 164
Acute, Hemorrhagic, Necrotizing Pancreatitis Associated With Riluzole Treatment in a Patient With Amyotrophic Lateral Sclerosis 162
Amyotrophic lateral sclerosis onset after prolonged treatment with a VEGF receptors inhibitor. 155
CHCH10 mutations in an Italian cohort of familial and sporadic amyotrophic lateral sclerosis patients 147
The role of arterial blood gas analysis (ABG) in amyotrophic lateral sclerosis respiratory monitoring 146
A PET/CT approach to spinal cord metabolism in amyotrophic lateral sclerosis 134
Secular trends of amyotrophic lateral sclerosis: The Piemonte and Valle d’Aosta register 132
The multistep hypothesis of ALS revisited: The role of genetic mutations 112
Cognitive correlates in amyotrophic lateral sclerosis: a population-based study in Italy. 111
Spatial epidemiology of Amyotrophic Lateral Sclerosis in Piedmont and Aosta Valley, Italy: a population-based cluster analysis 111
Does Recognition of Facial Expression of Primary and Social Emotions in ASL Patients Interfere with Social Competence? 110
ATXN2 polyQ intermediate repeats are a modifier of ALS survival. 107
Can eye-tracking system communication improve quality of life and mood in ALS patients with locked-in syndrome 107
Persistent idiopathic hypoglossal nerve palsy: A motor neuron disease-mimic syndrome? 104
18 F-FDG-PET correlates of cognitive impairment in ALS 102
A novel p.Ser108LeufsTer15 SOD1 mutation leading to the formation of a premature stop codon in an apparently sporadic ALS patient: insights into the underlying pathomechanisms 100
Correlation between Apolipoprotein E genotype and brain metabolism in amyotrophic lateral sclerosis 98
Expression of NOX2 protein in neutrophils of patients with ALS 96
Multicenter validation of [18F]-FDG PET and support-vector machine discriminant analysis in automatically classifying patients with amyotrophic lateral sclerosis versus controls 94
Genetic counselling in ALS: facts, uncertainties and clinical suggestions 93
Interplay between spinal cord and cerebral cortex metabolism in amyotrophic lateral sclerosis 82
Cognitive impairment across ALS clinical stages in a population-based cohort 81
Lithium carbonate does not prevent ALS: a case-report of four patients on long-term therapy for the treatment of bipolar disorder 80
NADPH oxidase (NOX2) activity is a modifier of survival in ALS 80
Are arterial hypertension and diabetes modifiers of ALS phenotype and outcome? A population-based study 80
Monocytes of patients with Amyotrophic Lateral Sclerosis linked to gene mutations display altered TDP-43 subcellular distribution 78
Does Recognition of Facial Expression of Primary and Social Emotions in ALS Patients Interfere with Social Competence? 75
Influence of cigarette smoking on ALS outcome: A population-based study 75
NADPH oxidase (NOX2) activity is a modifier of survival in ALS. 73
Metabolic spatial connectivity in amyotrophic lateral sclerosis as revealed by independent component analysis 73
ALS clinical trials: Do enrolled patients accurately represent the ALS population? 71
Validation of the Italian version of self-administered ALSFRS-R scale 68
Common polymorphisms of chemokine (C-X3-C motif) receptor 1 gene modify amyotrophic lateral sclerosis outcome: A population-based study 66
Frontotemporal dementia in three cases of familial amyotrophic lateral sclerosis with TARDBP A382T mutation 65
DETECTING COGNITIVE CHANGES IN ALS: A POPULATION-BASED STUDY 65
Prognostic influence of pre-morbid smoking habits, diabetes, arterial hypertension and vascular risk profile on phenotype and outcome of ALS patients: a population-based study. 65
A familial ALS case carrying a novel p.G147C SOD1 heterozygous missense mutation with non-executive cognitive impairment. 64
A novel p.E121G heterozygous missense mutation of SOD1 in an apparently sporadic ALS case with a 14-year course. 64
ALS Clinical Trials: Do the Enrolled Patients Represent the ALS Population? 61
Influence of arterial hypertension, type 2 diabetes and cardiovascular risk factors on ALS outcome: a population-based study 59
Amyotrophic lateral sclerosis/frontotemporal dementia with predominant manifestations of obsessive-compulsive disorder associated to GGGGCC expansion of the c9orf72 gene 59
An ALS-FTD Patient Carrying a Double Pathogenetic Mutation of C9ORF72 and TARDBP: Case Report 58
Segni e sintomi inusuali o rari in Neurologia 58
Early weight loss in amyotrophic lateral sclerosis: Outcome relevance and clinical correlates in a population-based cohort 57
What’s ALS? ALS clinical phenotypes in an Italian register 53
A de novo nonsense mutation of the FUS gene in an apparently familial amyotrophic lateral sclerosis case. 53
Cognitive Reserve in ALS with Comorbid Frontotemporal Dementia (FTD): A Population-Based Study 52
Genetic architecture of ALS in Sardinia. 52
ALS/FTD phenotype in two Sardinian families carrying both C9ORF72 and TARDBP mutations 51
An ALS case with a novel D90N-SOD1 heterozygous missense mutation 51
Pain in amyotrophic lateral sclerosis: a population-based controlled study 51
Pain in ALS: a case-control study 49
The role of APOE in the occurrence of frontotemporal dementia in amyotrophic lateral sclerosis 48
ALS phenotype is influenced by age, sex, and genetics: A population-based study 48
Parkinsonian traits in amyotrophic lateral sclerosis (ALS): a prospective population-based study 48
The interplay among education, brain metabolism, and cognitive impairment suggests a role of cognitive reserve in Amyotrophic Lateral Sclerosis 48
UNC13A influences survival in Italian amyotrophic lateral sclerosis patients: a population-based study 47
Monomelic amyotrophy is not always benign: A case report 46
Clinical phenotypes in amyotrophic lateral sclerosis: a population-based study in Italy 46
Lifetime sport practice and brain metabolism in Amyotrophic Lateral Sclerosis 46
Amyotrophic lateral sclerosis caregiver burden and patients’ quality of life during COVID-19 pandemic 46
Religiousness is positively associated with quality of life of ALS caregivers 45
TBK1 is associated with ALS and ALS-FTD in Sardinian patients 44
Regional spreading of symptoms at diagnosis as a prognostic marker in amyotrophic lateral sclerosis: A population-based study 43
Comorbidity of Cervical Spondylogenic Myelopathy and Amyotrophic Lateral Sclerosis: When Electromyography Makes the Difference in Diagnosis 43
Do ecological factors influence the clinical presentation of amyotrophic lateral sclerosis? 42
Telemedicine for patients with amyotrophic lateral sclerosis during COVID-19 pandemic: an Italian ALS referral center experience 41
Brain metabolic changes across King’s stages in amyotrophic lateral sclerosis: a 18F-2-fluoro-2-deoxy-d-glucose-positron emission tomography study 40
Differential neuropsychological profile of ALS patients with and without C9orf72 mutation 40
Association of Variants in the SPTLC1 Gene with Juvenile Amyotrophic Lateral Sclerosis 38
Decline of cognitive and behavioral functions in amyotrophic lateral sclerosis: a longitudinal study 38
A familial amyotrophic lateral sclerosis pedigree discordant for a novel p.Glu46Asp heterozygous OPTN variant and the p.Ala5Val heterozygous SOD1 missense mutation 37
TDP-43 real-time quaking induced conversion reaction optimization and detection of seeding activity in CSF of amyotrophic lateral sclerosis and frontotemporal dementia patients 37
Italian adaptation of the Beaumont Behavioral Inventory (BBI): psychometric properties and clinical usability 35
Brain metabolic correlates of apathy in amyotrophic lateral sclerosis: An 18F-FDG-positron emission tomography stud 34
Metabolic brain changes across different levels of cognitive impairment in ALS: a 18F-FDG-PET study 34
Amyotrophic lateral sclerosis with SOD1 mutations shows distinct brain metabolic changes 34
GBA variants influence cognitive status in amyotrophic lateral sclerosis 34
Effects of intracellular calcium accumulation on proteins encoded by the major genes underlying amyotrophic lateral sclerosis 33
Arterial blood gas analysis: base excess and carbonate are predictive of noninvasive ventilation adaptation and survival in amyotrophic lateral sclerosis 31
Developments in the assessment of non-motor disease progression in amyotrophic lateral sclerosis 30
Tailoring patients’ enrollment in ALS clinical trials: the effect of disease duration and vital capacity cutoffs 30
Plateaus in amyotrophic lateral sclerosis progression: results from a population-based cohort 30
Mutational Analysis of Known ALS Genes in an Italian Population-Based Cohort 30
A novel splice site FUS mutation in a familial ALS case: effects on protein expression 30
Prospective epidemiological registers: a valuable tool for uncovering ALS pathogenesis 28
The characteristics of cognitive impairment in als patients depend on the lateralization of motor damage 28
Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture 28
The heterozygous deletion c.1509_1510delAG in exon 14 of FUS causes an aggressive childhood-onset ALS with cognitive impairment 26
Neck flexor weakness at diagnosis predicts respiratory impairment in amyotrophic lateral sclerosis 26
Validation of the Italian version of the Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS) administered to patients and their caregivers 26
Prognostic role of slow vital capacity in amyotrophic lateral sclerosis 25
Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology 24
What is amyotrophic lateral sclerosis prevalence? 22
Social Cognition deficits in Amyotrophic Lateral Sclerosis: a pilot cross-sectional population-based study 21
Totale 7482
Categoria #
all - tutte 13982
article - articoli 0
book - libri 0
conference - conferenze 1909
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15891


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018466 0000 00 079 239852934
2018/2019711 45453245 3725 51112 366713185
2019/2020944 40353795 40110 12296 1301285556
2020/20211224 79888259 11497 88104 17711157168
2021/20221602 653180133 11975 8974 83172396285
2022/20231809 27624266228 224585 1853 0000
Totale 7647